Skip to main
ATR
ATR logo

Aptargroup (ATR) Stock Forecast & Price Target

Aptargroup (ATR) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 0%
Buy 100%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

AptarGroup has experienced substantial growth in its AMS Solutions segment, which has achieved a compound annual growth rate (CAGR) of approximately 10% and now constitutes about 11% of Pharma's revenue and 5% of total revenue for FY24. The company's Injectables business has also shown significant growth, marked by a 9% CAGR, driven by an increasing global demand for biologics and GLP-1 products. This combination of robust segment growth and a favorable market trend is expected to continue enhancing AptarGroup's profit margins and overall financial performance.

Bears say

AptarGroup faces significant risks that may impede its growth and profitability, particularly as its transition to a majority Pharma focus appears slower than anticipated, which could hinder margin expansion. Being a global entity, AptarGroup is exposed to various currency and country risks, as well as economic cycles that can adversely affect industry demand. Additionally, ongoing trade tensions, potential regulatory inspection failures, and challenges in protecting its intellectual property may further jeopardize its competitive position and overall financial performance.

Aptargroup (ATR) has been analyzed by 4 analysts, with a consensus rating of Buy. 0% of analysts recommend a Strong Buy, 100% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aptargroup and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aptargroup (ATR) Forecast

Analysts have given Aptargroup (ATR) a Buy based on their latest research and market trends.

According to 4 analysts, Aptargroup (ATR) has a Buy consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $167.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $167.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aptargroup (ATR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.